Ipswich Investment Management Co., Inc.
Source: SEC Form 13F · as of Mar 2026Ipswich Investment Management Co., Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $39.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$39.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 36,911 | $9.0M |
| LLYELI LILLY & Co | 6,297 | $5.8M |
| MRKMerck & Co., Inc. | 46,912 | $5.6M |
| AMGNAMGEN INC | 15,820 | $5.6M |
| ABBVAbbVie Inc. | 11,696 | $2.5M |
| NVSNovartis AG | 13,835 | $2.1M |
| NVONovo Nordisk A/S | 43,541 | $1.6M |
| CRSPCRISPR Therapeutics AG | 23,533 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,063 | $921K |
| BMYBRISTOL MYERS SQUIBB CO | 14,829 | $899K |
| ABTABBOTT LABORATORIES | 7,900 | $811K |
| PMPhilip Morris International Inc | 4,593 | $759K |
| GILDGILEAD SCIENCES, INC. | 4,165 | $580K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,526 | $471K |
| MEDPMedpace Holdings Inc. | 855 | $411K |
| IDXXIDEXX LABORATORIES INC /DE | 547 | $307K |
| PFEPFIZER INC | 9,121 | $256K |
| REGNREGENERON PHARMACEUTICALS, INC. | 264 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.